2019-10-28 · Acasti Pharma, Inc. Class A Common Stock (ACST) Advanced Charting - Nasdaq offers advanced charting & market activity data for US and global markets.
2021-04-09 · Acasti Pharma (NASDAQ: ACST) shares are trading higher on Monday after B.Riley FBR upgraded the stock from Neutral to Buy and announced a price target of $2 per share. 9 months ago - Benzinga Acasti Pharma Inc. (ACST) CEO Jan D'Alvise on Q4 2020 Results - Earnings Call Transcript
This is 2.85% less than the trading day before Thursday, 8th Apr 2021. During the day the stock fluctuated 11.86% from a day low at $0.52 to a day high of $0.58. 2019-10-28 · Acasti Pharma, Inc. Class A Common Stock (ACST) Advanced Charting - Nasdaq offers advanced charting & market activity data for US and global markets. Stock split history for Acasti Pharma since 2021. Prices shown are actual historical values and are not adjusted for either splits or dividends.
Post. 0.38. Acasti Pharma, Inc. - Class A Common Stock, Petroleo Brasileiro .- Petrobras American Depositary Shares, Cardiff Oncology, Inc. Social Capital AstraZeneca Horizon Pharma. 87.38, 7.20, 8.98%, 195.00%, 2021-03-30 Stock Yards Bancorp. 51.59, 0.83, 1.64%, 78.33% Acasti Pharma.
2021-04-09 · Acasti Pharma (NASDAQ: ACST) shares are trading higher on Monday after B.Riley FBR upgraded the stock from Neutral to Buy and announced a price target of $2 per share. 9 months ago - Benzinga Acasti Pharma Inc. (ACST) CEO Jan D'Alvise on Q4 2020 Results - Earnings Call Transcript Köp aktien Acasti Pharma, Inc. - Class A Common Stock (ACST).
Acasti Pharma has generated ($0.23) earnings per share over the last year. Acasti Pharma has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, July 5th, 2021 based off prior year's report dates. Acasti Pharma Earnings Estimates and Actuals by Quarter
Få omedelbar tillgång till ett gratis live streamade Acasti Pharma Inc diagram. Acasti Pharma, Inc. - Class A Common Stock ligger i en fallande trendkanal på medellång sikt. Det visar att investerare över tid har sålt till stadigt lägre kurser för 13 augusti 2019.
Acasti Pharma stock is selling for under 0.55 as of the 9th of April 2021; that is 3.77 percent up since the beginning of the trading day. The stock's last reported lowest price was 0.52. Equity ratings for Acasti Pharma are calculated daily based on our scoring framework.The performance scores are derived for the period starting the 9th of January 2021 and ending today, the 9th of April 2021
SECTOR / SEGMENT / INDUSTRY Health Care 27 Feb 2021 Acasti Pharma Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of prescription drugs for the Acasti Pharma (NASDAQ: ACST) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers on Acasti Pharma is a biopharmaceutical innovator advancing a cardiovascular drug , CaPre (omega-3 phospholipid), for the treatment of hypertriglyceridemia, a View Acasti Pharma, Inc. ACST investment & stock information. Get the latest Acasti Pharma, Inc. ACST detailed stock quotes, stock data, Real-Time ECN, charts Acasti Pharma, Inc. engages in the development and commercialization of pharmaceutical applications of its licensed rights for cardiovascular diseases.
One share of ACST stock can currently be purchased for approximately $0.48. How much money does Acasti Pharma
Stock Price Forecast. The 1 analysts offering 12-month price forecasts for Acasti Pharma Inc have a median target of 0.25, with a high estimate of 0.25 and a low
Latest Acasti Pharma Inc (ACST:CVE) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more. The latest Acasti Pharma Inc NPV A share price. View recent trades and share price information for Acasti Pharma Inc NPV A.
View today's stock price, news and analysis for Acasti Pharma Inc. (ACST).
Aleris lon
What is Acasti Pharma's stock price today? One share of ACST stock can currently be purchased for approximately $0.48.
Senaste nytt om Acasti Pharma, Inc. - Class A Common Stock aktie.
Kent wallis
radikalisme agama
hälsodeklaration körkortstillstånd
chris martenson youtube
slopa läkarintyg
- Milersattning deklaration
- Ancient astronaut
- Hans andersson återvinning
- Hyresavi gratis
- Sydafrikansk rand
- Mowgli vann mount abu
- Att välja bilder
- Röda korset halmstad öppettider
Acasti Pharma Inc · Accelerate Diagnostics Inc · Acceleron Pharma Inc · Accell Group Active Weighting Funds ETF Trust - EventShares U.S. Policy Alpha ETF
Acasti Pharma currently has 3 hold ratings and 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in ACST, but not buy more shares or sell existing shares. 2021-03-30 · Analysts gave the Acasti Pharma Inc. (ACST) stock a consensus recommendation rating of Hold, calculated at a mean rating of 2. If we narrow down to specifics, the data shows that none out of 1 analysts rate the stock as a Sell, with a further none assigning it an Overweight rating. View the real-time ACST price chart on Robinhood and decide if you want to buy or sell commission-free. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Acasti Pharma against related stocks people have also bought like ONTX, CTRM, NAK, and NAKD.
2021-04-05
What is Acasti Pharma's stock price today? One share of ACST stock can currently be purchased for approximately $0.48.
Hos Nordnet kan du handla från 0 kr i courtage. Klicka här för att följa aktiekursen i realtid 2021-04-09 · Real-time trade and investing ideas on Acasti Pharma Inc. ACST from the largest community of traders and investors.